ATE240722T1 - Transdermales abgabesystem, das ein östrogen enthält - Google Patents

Transdermales abgabesystem, das ein östrogen enthält

Info

Publication number
ATE240722T1
ATE240722T1 AT95928460T AT95928460T ATE240722T1 AT E240722 T1 ATE240722 T1 AT E240722T1 AT 95928460 T AT95928460 T AT 95928460T AT 95928460 T AT95928460 T AT 95928460T AT E240722 T1 ATE240722 T1 AT E240722T1
Authority
AT
Austria
Prior art keywords
pct
delivery system
transdermal delivery
estrogen
sec
Prior art date
Application number
AT95928460T
Other languages
English (en)
Inventor
Spiros Fotinos
Original Assignee
Lavipharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lavipharm Sa filed Critical Lavipharm Sa
Application granted granted Critical
Publication of ATE240722T1 publication Critical patent/ATE240722T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT95928460T 1994-07-26 1995-07-25 Transdermales abgabesystem, das ein östrogen enthält ATE240722T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR94100369 1994-07-26
PCT/EP1995/002938 WO1996003119A1 (en) 1994-07-26 1995-07-25 Transdermal delivery device containing an estrogen

Publications (1)

Publication Number Publication Date
ATE240722T1 true ATE240722T1 (de) 2003-06-15

Family

ID=10941554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95928460T ATE240722T1 (de) 1994-07-26 1995-07-25 Transdermales abgabesystem, das ein östrogen enthält

Country Status (11)

Country Link
US (1) US5925373A (de)
EP (1) EP0735867B1 (de)
JP (1) JP3043071B2 (de)
AT (1) ATE240722T1 (de)
AU (1) AU703074B2 (de)
BR (1) BR9506279A (de)
CA (1) CA2172265C (de)
DE (1) DE69530832T2 (de)
GR (1) GR1002079B (de)
NZ (1) NZ291161A (de)
WO (1) WO1996003119A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
GB9803032D0 (en) * 1998-02-12 1998-04-08 Ethical Pharmaceuticals Uk Lim Transdermal delivery devices
DE10000333A1 (de) * 2000-01-07 2001-07-19 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur transdermalen Verabreichung von Hormonen mit einem permeationsverbessernden Zusatzstoff
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
WO2005067897A1 (en) * 2004-01-14 2005-07-28 Lavipharm Laboratories, Inc. Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid
WO2008045461A2 (en) * 2006-10-11 2008-04-17 Oregon Health & Science University Transdermal diethylstilbestrol for treating prostate cancer
DE102006050558B4 (de) 2006-10-26 2009-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
US20090098191A1 (en) * 2007-10-16 2009-04-16 Anderson Christopher G Use of bases to stabilize transdermal formulations
WO2015031552A1 (en) * 2013-08-30 2015-03-05 3M Innovative Properties Company Estradiol containing transdermal drug delivery systems and compositions

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4789547A (en) * 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
DE68917292T2 (de) * 1988-02-26 1995-02-02 Riker Laboratories Inc Transdermales estradiol als therapeutisches sytem.
CA2004203A1 (en) * 1988-12-01 1990-06-01 Sharad K. Govil Compositions for transdermal delivery of estradiol
EP0399432B1 (de) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermales therapeutisches Mittel
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
CA2065311C (en) * 1989-09-08 2000-01-11 Chia-Ming Chiang Solid matrix system for transdermal drug delivery
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
US5248676A (en) 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations
AU653156B2 (en) * 1990-06-14 1994-09-22 Dermamed Transdermal administration to humans and animals
NZ240358A (en) * 1990-10-29 1994-09-27 Alza Corp Transdermal contraceptive device comprising (as active agents) an estrogen and a gestodene together with a skin permeation enhancer
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
MX9207344A (es) * 1991-12-16 1993-07-01 Alza Corp Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
US5670142A (en) * 1996-07-08 1997-09-23 Donald Neudecker Treatment for itch of chicken pox

Also Published As

Publication number Publication date
EP0735867B1 (de) 2003-05-21
US5925373A (en) 1999-07-20
WO1996003119A1 (en) 1996-02-08
NZ291161A (en) 1998-04-27
DE69530832D1 (de) 2003-06-26
JPH09503229A (ja) 1997-03-31
JP3043071B2 (ja) 2000-05-22
CA2172265C (en) 2004-04-20
DE69530832T2 (de) 2004-04-22
AU703074B2 (en) 1999-03-11
CA2172265A1 (en) 1996-02-08
EP0735867A1 (de) 1996-10-09
BR9506279A (pt) 1997-08-12
GR1002079B (en) 1995-12-05
AU3221495A (en) 1996-02-22

Similar Documents

Publication Publication Date Title
KR960703545A (ko) 테스토스테론의 공급을 위한 피부패치 및 방법(skin patches and methods for providing testosterone)
HUP9802326A2 (hu) 17-Dezacetil-norgesztimát vagy valamely ösztrogénnel kombinált hatóanyag bevitelére alkalmas transzdermális készítmény
NZ316026A (en) A transdermal therapeutic system (a hormone patch) in which drugs are contained which are released into the skin comprising a backing film and a pressure sensitive adhesive
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
RU98100451A (ru) Трансдермальный пластырь и способ введения 17-деацетилноргестимата отдельно или в сочетании с эстрогеном
DK0802789T3 (da) Estradiolholdigt plaster
ATA87488A (de) Mehrschichtiges transdermales therapeutisches system fuer die kombinierte applikation von oestrogen bzw. synthetischen oestrogen-wirksamen verbindungen mit synthetischen gestagenen
ATE42901T1 (de) Haftendes arzneimittelpraeparat fuer perkutane absorption.
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
ATE264098T1 (de) Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen
DE69205010D1 (en) Transdermales estradiol als therapeutisches system.
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
ATE240722T1 (de) Transdermales abgabesystem, das ein östrogen enthält
GR3032218T3 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives
ATE195430T1 (de) Niedrig dosierte steroidtabletten, die gallussäureester als antioxidans enthalten, verfahren zur herstellung und die verwendung
MY129733A (en) A pharmaceutical preparation adhering to the skin, in particular a tts, for the release of 17-(beta) estradiol to the human organism
DK1296662T3 (da) Dermalt terapeutisk system indeholdende 2-(3-benzophenyl)-propionsyre eller [o-(2,6-dichloranilino)-phenyl]-eddikesyre
ATE214271T1 (de) Transdermales arzneistoffverabreichungssystem zur behandlung von herzerkrankungen
MX9704291A (es) Sistema de liberacion transdermica con recubrimiento adhesivo y disco de sellado desprendible.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties